Therapeutic advances in neuromuscular diseases

Keyphrases

• Muscular Dystrophy 100%
• Neuromuscular Disease 100%
• Therapeutic Advances 100%
• Clinical Trials 33%
• Mechanism of Action 33%
• Therapeutic Efficacy 33%
• Autoimmune 33%
• Etiology 33%
• Controlled Experiment 33%
• Chemokines 33%
• Methotrexate 33%
• Immunomodulator 33%
• Cyclophosphamide 33%
• Plasmapheresis 33%
• Cyclosporine 33%
• Immunosuppressive Drugs 33%
• Oral Tolerance 33%
• Molecular Therapy 33%
• Gentamycin 33%
• Genetic Therapy 33%
• Albuterol 33%
• Myoblast Transplantation 33%
• Chlorambucil 33%
• Oxandrolone 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Muscular Dystrophy 100%
• Neuromuscular Disease 100%
• Glucocorticoid 66%
• Clinical Study 33%
• Gentamicin 33%
• Clinical Trial 33%
• Combination Therapy 33%
• Cytokine 33%
• Immunotherapy 33%
• Immunomodulating Agent 33%
• Immunosuppressive Agent 33%
• Methotrexate 33%
• Ciclosporin 33%
• Immunoglobulin 33%
• Chemokine 33%
• Cyclophosphamide 33%
• Salbutamol 33%
• Anabolic Steroid 33%
• Chlorambucil 33%
• Oxandrolone 33%